Project Grant R01AI179839
- This Project Grant award from the National Science Foundation's Biological Sciences program (CFDA 47.074) provides $844,975 to Northwestern University to conduct research on how the bacterial pathogen Salmonella Typhimurium makes rapid and accurate decisions to survive when engulfed by immune cells. The project aims to use quantitative approaches and live-cell imaging to track how Salmonella balances speed and accuracy in activating virulence genes to adapt to the intracellular environment of...
- The National Science Foundation awarded a two-year, $138,000 Project Grant under the Biological Sciences federal grant program (CFDA 47.074) to conduct research characterizing the genetic mechanisms of bacteria-phage coevolution in Listeria and Salmonella. The postdoctoral fellow will analyze the dynamic relationships between the foodborne pathogens Listeria monocytogenes and Salmonella enterica, and their bacteriophages. Through serial passaging experiments and whole genome sequencing, the...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $131,076 Project Grant to The Leland Stanford Junior University under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 4, 2025, with completion targeted for July 31, 2027. This award supports biomedical research investigating the functional understanding of genotypic and phenotypic diversity across Salmonella species, a pathogen responsible for over 100...
- The University of Utah was awarded a $728,244 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on the molecular mechanisms of Salmonella's type III secretion system. The goal is to develop a better understanding of how this critical virulence mechanism in Gram-negative pathogens, including Salmonella, Shigella, Vibrio, Pseudomonas, Yersinia, and Chlamydia, selects...
- This $536,250 Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports computational method development to advance single-cell transcriptomic data analysis. Awarded to Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, the project runs from July 1, 2025 through June 30, 2027 and develops knowledge-guided algorithms designed to improve the detection and...
- This $849,713 Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research to elucidate RNA-RNA interaction networks during interbacterial interactions involving the bacterium Pseudomonas aeruginosa. The research team at Boston Children's Hospital seeks to define the small RNA (sRNA) interaction network in P. aeruginosa and decode the regulatory roles played by sRNAs during its interactions with other bacteria. The project will...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $596,318 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Texas Southwestern Medical Center on February 10, 2026, with a completion date of January 31, 2031. This award funds basic and translational research designed to elucidate virulence factor functions in pathogenic bacteria, specifically investigating how Salmonella enterica...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $402,985 to the Research Institute at Nationwide Children's Hospital under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2027. This Project Grant supports the development and characterization of a collaborative cross mouse model (CC003 strain) that enables direct in vivo study of Salmonella Typhi chronic carriage—a...
- This $256,000 Project Grant from the National Science Foundation's Division of Industrial Innovation, under the Engineering program (CFDA 47.041), funds the development of a rapid, simple, and low-cost Salmonella detection and quantification test. Secure Food Solutions, Incorporated will optimize a multi-layer 96-well microplate method to demonstrate 90% sensitivity and specificity for Salmonella in raw poultry and processing environment samples within 15 hours without pre-enrichment. They...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $771,210 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct biomedical research on Salmonella persistence mechanisms. The award, effective February 19, 2026, with a completion date of January 31, 2031, supports research investigating how Salmonella enterica serovar Typhimurium (STM) maintains persistent...
HIGH-THROUGHPUT SINGLE-CELL RNA SEQUENCING OF BACTERIA TO UNCOVER CELL STATES INVOLVED IN PATHOGENESIS - BACTERIAL CELLS WITH THE SAME GENETIC MATERIAL CAN HAVE DIFFERENT TRANSCRIPTIONAL STATES. THESE DISTINCT TRANSCRIPTIONAL STATES ARE CRUCIAL TO MANY IMPORTANT PHYSIOLOGICAL FUNCTIONS, SUCH AS SPORULATION, MOTILITY, METABOLIC ADAPTATION, ANTIBIOTIC RESISTANCE, AND BIOFILM FORMATION. TO IDENTIFY THE DISTINCT TRANSCRIPTIONAL CELL STATES THAT ARE PRESENT IN A POPULATION OF BACTERIA, WE NEED TO MEASURE THE EXPRESSION LEVELS OF ALL GENES IN INDIVIDUAL BACTERIAL CELLS ACROSS A LARGE NUMBER OF CELLS. TO DO SO, WE HAVE RECENTLY DEVELOPED A METHOD, CALLED PROBAC- SEQ, WHICH EXTENDS THE POWER OF COMMERCIAL MICROFLUIDIC PLATFORMS FOR SINGLE-CELL RNA SEQUENCING OF MAMMALIAN CELLS TO BACTERIAL CELLS. OUR METHOD USES DNA PROBES WITH POLY-A TAILS TO TAG INDIVIDUAL TRANSCRIPTS IN FIXED BACTERIA. THE TAGGED BACTERIA ARE THEN PROCESSED WITH A COMMERCIAL PLATFORM FOR SINGLE-CELL RNA SEQUENCING (SUCH AS 10X) WHERE THE DNA PROBES ARE CAPTURED AND QUANTIFIED AS IF THEY WERE TRANSCRIPTS OF A MAMMALIAN CELL. IN PROOF- OF-PRINCIPLE EXPERIMENTS, WE HAVE APPLIED OUR METHOD TO E. COLI, BACILLUS, AND C. PERFRINGENS, IDENTIFYING KNOWN AND NEW TRANSCRIPTIONAL CELL STATES. HERE, WE PROPOSE TO EXTEND PROBAC-SEQ TO ENABLE PROFILING OF HUNDREDS OF THOUSANDS OF INDIVIDUAL BACTERIAL CELLS IN A SINGLE RUN AND APPLY IT TO CREATE AN ATLAS OF TRANSCRIPTIONAL CELL STATES OF SALMONELLA ENTERICA DURING INFECTION. SALMONELLA IS AN IMPORTANT HUMAN PATHOGEN AND A MAJOR CAUSE OF FOODBORNE ILLNESSES. INTRIGUINGLY, PATHOGENIC STRAINS OF SALMONELLA OFTEN EXIST ASYMPTOMATICALLY IN PEOPLE. IN ADDITION, SALMONELLA CAN INFECT A WIDE VARIETY OF CELL TYPES, COLONIZE DIFFERENT NICHES, AND INTERACT WITH THE IMMUNE CELLS AND GUT MICROBIOME. THEREFORE, TO UNDERSTAND PATHOGENICITY OF SALMONELLA AND DEVISE EFFECTIVE THERAPIES, WE NEED TO IDENTIFY WHAT CELL STATES ARE PRESENT DURING INFECTION, HOW CELLS TRANSITION BETWEEN THESE STATES, AND AT WHAT RATES. TO ANSWER THIS QUESTION, WE WILL DEVELOP A HIGH THROUGH-PUT PLATFORM FOR COST-EFFECTIVE SINGLE-CELL RNA SEQUENCING OF BACTERIA (AIM 1). WE WILL INCORPORATE MULTIPLEXING INTO PROBAC-SEQ TO INCREASE CELL NUMBERS, IMPLEMENT PROTEIN READOUT USING DNA-TAGGED ANTIBODIES, AND DEVELOP A METHOD FOR ENRICHING FOR A PARTICULAR SPECIES OF BACTERIA FROM A MIXTURE OF SPECIES PRIOR TO SINGLE-CELL PROFILING. CRITICALLY, WE WILL BUILD THE COMPUTATIONAL FRAMEWORKS NEEDED FOR DATA ANALYSIS. OUR PLATFORM WILL BE BROADLY USEFUL. WE WILL THEREFORE OPENLY SHARE REAGENTS, PROTOCOLS, AND COMPUTATIONAL PIPELINES. IN AIM 2, WE WILL APPLY OUR PLATFORM TO CREATE AN ATLAS OF TRANSCRIPTIONAL CELL STATES OF SALMONELLA DURING INFECTION IN CULTURE AND USING AN IN VITRO MODEL OF INTESTINAL ORGANOIDS. WE WILL INFER HOW DISTINCT CELL STATES INTERACT WITH EACH OTHER, HOW THEY ARE REGULATED, AND THE DYNAMICS OF TRANSITIONS BETWEEN THEM. WE WILL IDENTIFY PERTURBATIONS THAT DISRUPT THE VIRULENT CELL STATE OR HINDER TRANSITIONS INTO THAT STATE. IN AIM 3, WE WILL VALIDATE OUR FINDINGS IN AN IN VIVO MODEL OF INFECTION USING GNOTOBIOTIC MICE. WE WILL ALSO MEASURE THE INTERACTIONS BETWEEN THE GUT MICROBIOME AND CELL STATES OF SALMONELLA USING GNOTOBIOTIC MICE COLONIZED WITH NATURALLY ACQUIRED MICROBIOTA. OUR FINDINGS CAN POTENTIALLY TRANSFORM OUR UNDERSTANDING OF PATHOGENICITY OF SALMONELLA. THE TOOLS DEVELOPED HERE CAN BE BROADLY APPLIED TO OTHER BACTERIAL SYSTEMS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $813.3k | 5/6/25 | ||
| Not listed | $81.3k | 9/4/24 | ||
| Not listed | $81.3k | 9/4/24 | ||
| Not listed | $751.4k | 6/20/24 | ||
| Not listed | $751.4k | 6/20/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
PO1681443S | University Of North Carolina At Chapel Hill | Project Grant R01AI179839 | $377.2k | 9/19/24 |